Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: Healthcare system and patient perspectives

PharmacoEconomics

Volumn 25, Issue 5, 2007, Pages 397-411

  Scott, Anthony ^a,b   Tinelli, Michela ^a   Bond, Christine ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LOOP DIURETIC AGENT; NON PRESCRIPTION DRUG; POTASSIUM CHANNEL BLOCKING AGENT; THIAZIDE DIURETIC AGENT;

ARTICLE; COMPUTER AIDED DESIGN; COST MINIMIZATION ANALYSIS; DRUG INDUSTRY; FOLLOW UP; GENERAL PRACTICE; GEOGRAPHY; HEALTH CARE SYSTEM; HOSPITAL ORGANIZATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MEDICAL RECORD; PHARMACIST; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRAINING; UNITED KINGDOM;

COMMUNITY PHARMACY SERVICES; CORONARY DISEASE; COSTS AND COST ANALYSIS; DATA COLLECTION; DELIVERY OF HEALTH CARE; DRUG COSTS; ENGLAND; HUMANS; MULTICENTER STUDIES; PATIENTS; STATE MEDICINE;

EID: 34248386885     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200725050-00004     Document Type: Article

References (24)

1. Marmot M, Elliott P. Coronary heart disease epidemiology: from aetiology to public health. 2nd ed. London: Oxford University Press, 2005
2. British Heart Foundation Statistics. Health survey for England 2003 [online]. Available from URL: http://www.heartstats.org [Accessed 2007 Mar 31]
3. Department of Health. National service framework for coronary heart disease, 2000 [online]. Available from URL: http://www.dh.gov.uk/ PolicyAndGuidance/HealthAndSocialCare Topics/CoronaryHeartDisease/ CoronaryArticle/fs/en?.cont ent_ID=4108602&chk=nf93gd [Accessed 2006 Feb 28]
4. Lutener S, Rhodes H. What do the contract regulations mean? Pharmaceutical J 2005; 275: 692-3
5. Departments of General Practice and Primary Care, and Management Studies, University of Aberdeen. Evolution and change in community pharmacy: synopsis, November 2003. London: Royal Pharmaceutical Society of Great Britain, 2003 [online]. Available from URL: http://www.rpsgb.org.uk/pdfs/chevcommphsyn.pdf [Accessed 2006 Feb 28]
6. The Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomised controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. J Fam Pract 2007; 24 (2) [online]. Available from URL: http://fampra. oxfordjournals.org/current. dtl#randomised_controlled_trial [Accessed 2007 Apr 23]
7. National Prescribing Centre (NPC). Medicines management [online]. Available from URL: http://www.npc.co.uk/mms/ mmsc/index.htm [Accessed 2006 Sep 30]
8. Briggs A, O'Brien BJ. The death of cost-minimisation analysis. Health Econ 2001; 10: 179-84
9. British National Formulary. 46th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2003
10. Chemist and Druggist directory 2003. Tonbridge: CMP Information Limited, 2002
11. Proprietor's Association of Great Britain (PAGB). OTC directory 2002/03: treatment for common ailments. London: PAGB, 2003
12. Netten A, Curtis L. Unit costs of health and social care. Canterbury: University of Kent, 2003
13. NHS reference costs [online]. Available from URL: http://www.doh.gov.uk/ nhsexec/REFCOSTS/2002appl.xls [Accessed 2004 Jan 31]
14. Automobile Association (AA) motoring costs 2002 [online]. Available from URL: http://www.theaa.com/staticdocs/pdf/allaboutcars/fuel/petrol2002.pdf [Accessed 2004 Apr 30]
15. HM Treasury. The green book: appraisal and evaluation in central government. London: The Stationary Office, 2003
16. Department of Transport. COBA 9 manual. London: Department of Transport, 1989
17. Vickers A, Altman D. Analysing controlled trials with baseline and follow-up measurements. BMJ 2001; 233: 1123-4
18. Wooldridge JM. Econometric analysis of cross section and panel data. Cambridge (MA): MIT Press, 2002
19. Greene W. Econometric analysis. 5th ed. New Jersey (NJ): Prentice Hall, 2003
20. Heckman J. Sample selection bias as a specification error. Econometrica 1979; 47: 153-61
21. Liu JL, Maniadakis N, Gray A, et al. The economic burden of coronary heart disease in the UK. Heart 2002; 88: 597-603
22. Pacini M, Smith R, Wilson E, et al. Home-based medication review in older people: is it cost effective? Pharmacoeconomics 2007; 25 (2): 171-80
23. Reilly V, Cavanagh M. The clinical and economic impact of a secondary heart disease prevention clinic jointly implemented by practice nurse and pharmacist. Pharm World Sci 2003; 25: 294-8
24. Last JM. A dictionary of epidemiology. Oxford: Oxford University Press, 2001